Litcius/Paper detail

Efbemalenograstim Alfa: First Approval

Hannah A. Blair

2023Drugs16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNeutropeniaFebrile neutropeniaChemotherapyInternal medicineIntensive care medicinePharmacotherapyOncologyPharmacologyNeutropenia and Cancer InfectionsBlood disorders and treatmentsBacterial Identification and Susceptibility Testing
Efbemalenograstim Alfa: First Approval | Litcius